Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Cramer

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
The American Journal of Managed Care|May 26, 1999
Consequences of intermittent treatment for hypertension: the case for medication compliance and persistenceJ A Cramer
Advances in Neurology|December 31, 1997
Alternate endpoints for seizure measurementJ A Cramer
Drugs & Aging|February 19, 1998
Enhancing patient compliance in the elderly. Role of packaging aids and monitoringJ A Cramer
Neurology|December 22, 1999
Oxcarbazepine in a monotherapy trial for partial seizures--placebo-controlled studies in neurology: where do they stop?J A Cramer
Archives of Internal Medicine|June 1, 1991
Medication compliance in epilepsyJ A Cramer
Neurology|September 25, 1999
Quality of life assessment in clinical practiceJ A Cramer
Current Opinion in Neurology|March 23, 2001
Assessing the severity of seizures and epilepsy: which scales are valid?J A Cramer
Neurology|February 1, 1995
Optimizing long-term patient complianceJ A Cramer
The Journal of Nervous and Mental Disease|February 10, 1999
Enhancing medication compliance for people with serious mental illnessJ A Cramer, R Rosenheck
Psychiatric Services (Washington, D.C.)|May 9, 1998
Compliance with medication regimens for mental and physical disordersJ A Cramer, R Rosenheck
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
The American Journal of Managed Care|May 26, 1999
Consequences of intermittent treatment for hypertension: the case for medication compliance and persistenceJ A Cramer
Advances in Neurology|December 31, 1997
Alternate endpoints for seizure measurementJ A Cramer
Drugs & Aging|February 19, 1998
Enhancing patient compliance in the elderly. Role of packaging aids and monitoringJ A Cramer
Neurology|December 22, 1999
Oxcarbazepine in a monotherapy trial for partial seizures--placebo-controlled studies in neurology: where do they stop?J A Cramer
Archives of Internal Medicine|June 1, 1991
Medication compliance in epilepsyJ A Cramer
Neurology|September 25, 1999
Quality of life assessment in clinical practiceJ A Cramer
Current Opinion in Neurology|March 23, 2001
Assessing the severity of seizures and epilepsy: which scales are valid?J A Cramer
Neurology|February 1, 1995
Optimizing long-term patient complianceJ A Cramer
The Journal of Nervous and Mental Disease|February 10, 1999
Enhancing medication compliance for people with serious mental illnessJ A Cramer, R Rosenheck
Psychiatric Services (Washington, D.C.)|May 9, 1998
Compliance with medication regimens for mental and physical disordersJ A Cramer, R Rosenheck
Pageof 12